IRCT20210913052453N1已完成2 期
Administration of Zinc-Chelating Agents (intravenuosly CaNa2EDTA) in COVID-19 Patients: A pilot study
Asadabad University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Patients with Covid-19 admitted to the Intensive Care Unit (ICU)
- •Patients with Covid-19 with respiratory distress
排除标准
- •insulin-dependent diabetic patients
- •Patients with urinary tract disorders
- •Patients with cardiovascular system disorders
研究者
相似试验
已完成
3 期
Zinc in addition to antibiotics for treating newborn babies with sepsisCTRI/2017/02/007966Translational Health Science and Technology Institute2,913
招募中
不适用
The effects of oral zinc syrup in the treatment of acute diarrhea in childreAcute diarrhea patientsMedian time to recoveryStool frequencyAcute diarrheaTCTR20160114002an Hospital224
已完成
不适用
sefulness of zinc preparation administration in zinc deficiency dialysis patientsJPRN-UMIN000042511Kawashima Hospital Group100
招募中
不适用
The study for usefullness of zinc administration in patients with chronic liver diseaseschronic liver diseasesJPRN-UMIN000032023Osaka-Rosai Hospital200
已完成
2 期
zinc supplement for diarrheaTCTR20190423004Srinakharinwirot University80